How is a 17 per cent increase for 10 consecutive years?

China Traditional Chinese Medicine Co., Ltd., located in Shunde RongguiDai Jiaxin"These days I have to go to Shanghai and Hangzhou first, come back and talk to you in detail." "On June 3rd, the first day of work after the Dragon Boat Festival, Huang Palmin, who manages Guangdong Global Pharmaceutical Co., Ltdunder the jurisdiction of China Traditional Chinese Medicine Co., Ltd("Global Pharmaceuticals") has ushered in a new round of busyis not just Huang's, all parts of the world are running at high speedThe strong momentum they have gathered has brought to the rapid development of the globeSince 2004, Global has maintained an annual sales growth rate of more than 17% of the momentum, Shunde pharmaceutical industry is a well-deserved leaderat a time when domestic and foreign markets are in a slump, why can Global maintain 10 consecutive years of rapid growth? What is its "one-door cheat"? the collision ofcapitalthe 20-year history of the development of the world, the combination of capital and strength has become an important driver of its progressEvery capital collision brings positive energy to the enterprisedrove from Shunde Daliang to Ronggui, passing the Rongqi Bridge, the bridge head to the left is Colong, right is Global Pharmaceuticals and its controlling shareholder - China Traditional Chinese Medicine Co., Ltdmanagement headquartersGlobal Pharma is growing steadily in a geographical location that Huang describes as "standing on the portal of Ronggui"Since 2004, Global Pharma's sales have risen by more than 17% a year, making it the well-deserved NO1 in the Shunde pharmaceutical industryLast year, the leading product yu screen particles have developed into annual sales of 250 million yuan of products, and SanTongping (nitrogen benzene flat release film) is also a sales of more than 100 million products "This proves that the company's strategic positioning and product market positioning established that year are effective Huang said , now vice president of Chinese Medicine Co., Ltd., Huang Palming is one of the elders of Global Pharmaceuticals, since the start of global pharmaceutical construction, he has been here to fight, watching it from dental language to grow "The biggest feature of Global Pharma is its willingness to absorb foreign resources and grow itself Huang said frankly in fact, the power of capital has been used to the fullest since Global Pharma was founded was established in 1993 by Guangdong Global Pharmaceutical Co., Ltd., which was jointly invested by Rongqi Town, Guangdong Medical College and Hong Kong Rongsheng Group Co., Ltd., which opened the first stage of cooperation between Guangdong Province, industry and research, and caused a sensation in the province use the power of capital to further strengthen the enterprise to become the consensus of all "We're increasingly finding that it's not possible to go it alone, and we have to find stronger partners and a bigger platform Huang said 20 years of global pharmaceutical development history, the combination of capital and strength has become an important driver of its progress In 1997, Global Pharmaceuticals and Japan Otsuka Co., Ltd joint venture changed its name to Guangdong Global Otsuka Pharmaceutical Co., Ltd.; Until 2013, The shareholders of Yingtian Pharmaceuticals, considering the long-term development of the enterprise, introduced China Pharmaceutical Group Corporation (hereafter referred to as Guopharma Group) as the company's largest shareholder, and Global Pharmaceuticals became a member of China Pharmaceuticals (600056, share bar) group At present, Yingtian Pharmaceutical officially changed its name to "Chinese Traditional Medicine Co., Ltd." Huang Palming is proud to say that every capital collision brings positive energy to the enterprise "For example, this time we "by the big money", China Traditional Chinese Medicine Co., Ltd has become the platform of the Chinese medicine industry sector, to the development of enterprises have brought the coveted resources, including capital, technology, new products, channels and so on "
and Global Pharma's sales data can be seen visually It is reported that in 2004, the global tax revenue in about 114 million, to last year has grown to about 420 million "Double-digit growth is expected in 2014 Huang said Behind the development of the now global pharmaceutical gradually formed a enterprise as the main body, research institutes as the support, market-oriented, products as the core, the combination of industry, research and research pharmaceutical innovation system why does Global Pharma attract the attention of foreign capital? In Huang's view, "research and development" of this sword is the bottom line of global pharmaceutical according to Huang Palming, the , now global pharmaceutical gradually formed a enterprise as the main body, research institutes as the support, market-oriented, products as the core, the combination of industry, research and development of pharmaceutical innovation system The company spends 5% of its annual sales revenue as a special fund for research and development for the research and development of new products and technologies and the optimization of processes Over the years, Global Pharma has established a technology innovation system with the enterprise technology center as its core, and encouraged technological innovation In 1995, Global Pharma took the lead in setting up the Guangdong Province Technology Research and Development Center for Controlled Release Preparations, in 2001 it established the Guangdong Traditional Chinese Medicine Technology Research and Development Center, and in 2004 it established the Foshan Pharmaceutical New Preparation Technology Research and Development Center practice has proved that the technology center has played a significant role in the development of global pharmaceutical Huang said that the center not only for the traditional Chinese medicine jade screen particles, raw vein capsules, small Chaihu tablets and other products to improve quality standards, but also make a number of products become the national Chinese medicine protection varieties and domestic exclusive products "At the same time, the implementation of quality as the core of the boutique project, these are the fundamental guarantee of the rapid development of enterprises "
Global also integrates social resources and forms strategic partnerships with many universities and institutions A joint laboratory for the development of new drugs has been set up with Zhongshan University to jointly develop new chinese medicine varieties with intellectual property rights, a new drug project for the development of compound slow release technology with the Guangzhou Institute of Pharmaceutical Industry, and a new type of new drug development in cooperation with the Chinese Pharmaceutical Industry Research Institute Thus, it effectively improves the research and development capability, the speed of research and development and the quality of research and development at the same time, Global was one of shunde's earlier postdoctoral workstationcompanies "The postdoctoral students we introduced were different from other companies, and after the introduction they were all doing research in schools so that they could do research in their most comfortable environment, and we just decided on the subject and funded it Huang said it would be welcome if they were willing to work for a business, but if they were not willing to continue to work together in this way to maximize the use of resources these postdoctoral work is to do around the existing drugs of Global Pharmaceuticals to do new uses, pharmacological efficacy and other forward-looking technology research, mining the new scientific connotation of products and market value added, the formation of a new impetus for enterprise development (310328, fund bar) Huang said the findings will be a technical reserve for Global Pharma, which could be left for future use even if it is not available for the time being He said, for example, that the development direction of jade screen particles can be so clear, and the previous post-doctoral research results are inseparable with the support of strong scientific research force, at present, Global has become one of the pioneers and leaders in the national pharmaceutical industry in the areas of film coating technology, quality standards of traditional Chinese medicine, slow-control release preparations, etc the power of technology
In recent years, Global Pharma has been able to grow rapidly, not by expanding the scale, but by relying on technological transformation, continuously improve the level of production automation, and continue to improve labor productivity Although Global Pharma has a strong research and development force, but the special nature of the pharmaceutical industry decided that its products can not be as fast as home appliances to launch new products " drug products take time to precipitate A brand-new drug cannot be produced without 8 to 10 years of development Huang said that even in the country's already well-known Saint Tongping, from 2004 to date continueto research and development he told reporters that in recent years, global pharmaceutical can have rapid growth, not by scale, but by technological transformation, continue to improve the level of automation in the production process.